Preparation and in vitro evaluation of donepezil hydrochloride orodispersible tablets

نویسندگان

چکیده

Objective: The present study was aimed to prepare and evaluate Donepezil HCl Orodispersible tablets (DO-ODTs) using natural synthetic superdisintegrants increase patient compliance. Methods: Direct compression adapted crospovidone, croscarmellose sodium as mucilage isolated from fruits of Abelmoschus esculentus at different concentrations along with microcrystalline cellulose aerosil. powder mixture were subjected for pre post evaluation including FTIR spectroscopy, micromeritic properties, tablet weight variation, hardness, friability, drug content, wetting time, dispersion water absorption ration, disintegration time in vitro release. Results: low SD indicate the content uniform, suggest no interaction between excipients used. DO-ODTs prepared higher concentration shows better release relative properties than crospovidone esculentus. Conclusion: results this work reveals that absorption, dispersion, rapid fast good further conclude can be efficiently successfully formulated by direct method.

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Preparation and In-Vitro Evaluation of Donepezil Hydrochloride Sustained Release Matrix Tablets Using Non-Gelling Polymer

The aim of the current investigation was to develop a Sustained release tablet of Donepezil Hydrochloride using nongelling polymer in order to overcome the problem of dose dumping. Viscarin GP-209 was used as a non-gelling release modifying agent. The formulated granule blends were evaluated for powder properties. Prepared tablets were subjected to post compression evaluations. In-vitro dissolu...

متن کامل

Preparation and evaluation of taste-masked donepezil hydrochloride orally disintegrating tablets.

The purpose of this research was to prepare and evaluate a non-bitter donepezil hydrochloride (DH) orally disintegrating tablet (ODT) for enhanced patient compliance. Taste masking was done by preparing microspheres with different ratios of drug and Eudragit EPO using spray drying method. The entrapment of the drug into microspheres was confirmed by scanning electron microscope (SEM) and X-ray ...

متن کامل

Formulation and In-vitro Evaluation of Aceclofenac Orodispersible Tablets

The object of the study was to formulate and evaluate Aceclofenac orodispersible tablets (ODT) by wet granulation method using different super disintegrants in different concentrations. Orodispersible tablets produce rapid dissolution of drug and absorption thereby producing rapid onset of action. Five batches (AFD1, AFD2, AFD3, AFD4, AFD5) of Aceclofenac orodispersible tablets were prepared an...

متن کامل

Preparation and in Vitro Drug Release Evaluation of Once-Daily Metformin Hydrochloride Sustained-Release Tablets

The objective of this study was to develop once-daily metformin hydrochloride sustained-release tablets (MHSRT) and evaluate their in vitro release behavior. MHSRT were prepared by the film coating method. The in vitro drug release rate of MHSRT and the commercial tablets Fortamet made in the United States of America in water was fitted with zero order kinetic equation, and Ritger-Peppas kineti...

متن کامل

Formulation and Evaluation of Fast Disintegrating Orodispersible Tablets of Ondansetron Hydrochloride

The demand for mouth dissolving tablets has been growing, during the last decade especially for geriatric and pediatric patients because of swallowing difficulties. The purpose of this research was to mask the intensely bitter taste of Ondansetron HCl and to formulate a orodispersible of the taste-masked drug. Taste masking was done by complexing Ondansetron HCl with Kyron T-134 in different ra...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: GSC Advanced Research and Reviews

سال: 2023

ISSN: ['2582-4597']

DOI: https://doi.org/10.30574/gscarr.2023.15.3.0153